BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15655352)

  • 1. The ARF tumor suppressor: keeping Myc on a leash.
    Gregory MA; Qi Y; Hann SR
    Cell Cycle; 2005 Feb; 4(2):249-52. PubMed ID: 15655352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p19ARF directly and differentially controls the functions of c-Myc independently of p53.
    Qi Y; Gregory MA; Li Z; Brousal JP; West K; Hann SR
    Nature; 2004 Oct; 431(7009):712-7. PubMed ID: 15361884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory Network of ARF in Cancer Development.
    Ko A; Han SY; Song J
    Mol Cells; 2018 May; 41(5):381-389. PubMed ID: 29665672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
    Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
    Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myc-ARF (alternate reading frame) interaction inhibits the functions of Myc.
    Datta A; Nag A; Pan W; Hay N; Gartel AL; Colamonici O; Mori Y; Raychaudhuri P
    J Biol Chem; 2004 Aug; 279(35):36698-707. PubMed ID: 15199070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Myc function by ARF: checkpoint for Myc-induced oncogenesis.
    Sarkar D; Fisher PB
    Cancer Biol Ther; 2006 Jun; 5(6):693-5. PubMed ID: 16775430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cancer cells escape from failsafe programs in a simple Twist].
    Puisieux A; Valsesia-Wittmann S
    Bull Cancer; 2006 Mar; 93(3):251-6. PubMed ID: 16567311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arf induces p53-dependent and -independent antiproliferative genes.
    Kuo ML; Duncavage EJ; Mathew R; den Besten W; Pei D; Naeve D; Yamamoto T; Cheng C; Sherr CJ; Roussel MF
    Cancer Res; 2003 Mar; 63(5):1046-53. PubMed ID: 12615721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells.
    Valsesia-Wittmann S; Magdeleine M; Dupasquier S; Garin E; Jallas AC; Combaret V; Krause A; Leissner P; Puisieux A
    Cancer Cell; 2004 Dec; 6(6):625-30. PubMed ID: 15607966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
    Haviernik P; Schmidt M; Hu X; Wolff L
    Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor.
    Chen D; Kon N; Li M; Zhang W; Qin J; Gu W
    Cell; 2005 Jul; 121(7):1071-83. PubMed ID: 15989956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic down-regulation of ARF expression is a selection step in immortalization of human fibroblasts by c-Myc.
    Benanti JA; Wang ML; Myers HE; Robinson KL; Grandori C; Galloway DA
    Mol Cancer Res; 2007 Nov; 5(11):1181-9. PubMed ID: 17982115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-xL gain of function and p19 ARF loss of function cooperate oncogenically with Myc in vivo by distinct mechanisms.
    Finch A; Prescott J; Shchors K; Hunt A; Soucek L; Dansen TB; Swigart LB; Evan GI
    Cancer Cell; 2006 Aug; 10(2):113-20. PubMed ID: 16904610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53- and Mdm2-independent repression of NF-kappa B transactivation by the ARF tumor suppressor.
    Rocha S; Campbell KJ; Perkins ND
    Mol Cell; 2003 Jul; 12(1):15-25. PubMed ID: 12887889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of function tp53 mutations do not accelerate the onset of myc-induced T-cell acute lymphoblastic leukaemia in the zebrafish.
    Gutierrez A; Feng H; Stevenson K; Neuberg DS; Calzada O; Zhou Y; Langenau DM; Look AT
    Br J Haematol; 2014 Jul; 166(1):84-90. PubMed ID: 24690081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects on ARF stability by normal versus oncogenic levels of c-Myc expression.
    Chen D; Kon N; Zhong J; Zhang P; Yu L; Gu W
    Mol Cell; 2013 Jul; 51(1):46-56. PubMed ID: 23747016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF.
    Jacobs JJ; Scheijen B; Voncken JW; Kieboom K; Berns A; van Lohuizen M
    Genes Dev; 1999 Oct; 13(20):2678-90. PubMed ID: 10541554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis.
    Hemmati PG; Gillissen B; von Haefen C; Wendt J; Stärck L; Güner D; Dörken B; Daniel PT
    Oncogene; 2002 May; 21(20):3149-61. PubMed ID: 12082630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation.
    Nilsson JA; Keller UB; Baudino TA; Yang C; Norton S; Old JA; Nilsson LM; Neale G; Kramer DL; Porter CW; Cleveland JL
    Cancer Cell; 2005 May; 7(5):433-44. PubMed ID: 15894264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mimicking p14ARF phosphorylation influences its ability to restrain cell proliferation.
    Vivo M; Ranieri M; Sansone F; Santoriello C; Calogero RA; Calabrò V; Pollice A; La Mantia G
    PLoS One; 2013; 8(1):e53631. PubMed ID: 23308265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.